About

This multi-society guideline was developed by the ACC and AHA along with other organizations and imaging societies, and represents the first-ever U.S. or international guideline for the evaluation and diagnosis of patients with acute or stable chest pain.

Here are some key points:

• Recommendation of deferral of testing in low-risk individuals
• Provides contemporary models to estimate risk/pre-test probability of CAD
• Provides specific recommendations for the evaluation of non-obstructive CAD
• Emphasizes more selective use of imaging and incorporation of contemporary imaging techniques
• Emphasizes intensification of preventive therapies
• Highlights the unique aspects of evaluating women with chest pain, including microvascular disease and ischemia with non-obstructive CAD
• Moves away from atypical chest pain as a descriptor
• Recommendation of incorporating prior test results when deciding on patient management and need/type of testing, including warranty period of prior normal CCTA and stress test results
• Lists factors to consider when selecting between CCTA and stress testing
• Detailed recommendations on evaluating non-cardiac causes of chest pain

Other key points for patients and clinicians were outlined in an editorial in JACC Cardiovascular Imaging, written by the guideline authors.

READ FULL EDITORIAL

webinars